Outcomes following coronary stenting in the era of bare-metal vs the era of drug-eluting stents.

  title={Outcomes following coronary stenting in the era of bare-metal vs the era of drug-eluting stents.},
  author={David J. Malenka and Aaron V. Kaplan and Frances Leslie Lucas and Sandra Sharp and Jonathan S. Skinner},
  volume={299 24},
CONTEXT Although drug-eluting stents reduce restenosis rates relative to bare-metal stents, concerns have been raised that drug-eluting stents may also be associated with an increased risk of stent thrombosis. Our study focused on the effect of stent type on population-based interventional outcomes. OBJECTIVE To compare outcomes of Medicare beneficiaries who underwent nonemergent coronary stenting before and after the availability of drug-eluting stents. DESIGN, SETTING, AND PATIENTS… CONTINUE READING
Highly Cited
This paper has 55 citations. REVIEW CITATIONS


Publications citing this paper.
Showing 1-10 of 33 extracted citations

Considerations in patients receiving oral antiplatelet therapy after acute coronary syndrome and percutaneous coronary intervention.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists • 2010
View 4 Excerpts
Highly Influenced

55 Citations

Citations per Year
Semantic Scholar estimates that this publication has 55 citations based on the available data.

See our FAQ for additional information.


Publications referenced by this paper.
Showing 1-10 of 48 references

Compari - son of coronary artery stenting outcomes in the eras before and after the introduction of drug - eluting stents

JA Spertus, R Kettelkamp, C Vance
Circulation • 2008

Late clinical events after clopidogrel discontinuation may limit the benefit of STENTING IN THE ERA OF BARE METAL VS THE ERA OF DRUG ELUTING STENTS ©2008 American Medical Association

M Pfisterer, HP Brunner-LaRocca, PT Buser, BASKET LATE Investigators
All rights reserved. (Reprinted) JAMA, June 25, • 2008